GL1X · GenesisL1 explorer

Research workbench

HIV integrase core domain in complex with inhibitor 2-(5-methyl-2-(2- (thiophen-2-YL)ETHYNYL)-1-benzofuran-3-YL)ACETIC acid

Analyse HIV integrase core domain in complex with inhibitor 2-(5-methyl-2-(2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6W42
Type
protein
Length
139 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV integrase catalytic domain
EC
2.7.7.49
Ligands
SJY, IOD, SO4

Structure

x-ray diffraction · 1 distinct chain · 50% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV integrase catalytic domain (EC 2.7.7.49)protein13950% helix, 22% strand—

Ligands and binding sites

  • SJY · 2-[5-methyl-2-(2-thiophen-2-ylethynyl)-1-benzofuran-3-yl]ethanoic acid · ligand · chains A
  • IOD · Iodide ion · ion · 4 copies · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Modifications

Observed in the structure: 2 modified (oxidation).

Compared structures

  • 6W42 · HIV Integrase core domain in complex with inhibitor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.